FACTORS ASSOCIATED WITH NON-ADHERENCE TO HEPATITIS B VIRUS ANTIVIRAL THERAPY

FACTORS ASSOCIATED WITH NON-ADHERENCE TO HEPATITIS B VIRUS ANTIVIRAL THERAPY

Objective: To assess the adherence to antivirals in Hepatitis B Virus (HBV) infected patients and to determine various social and demographic factors which can have an impact on it. Study Design: Cross- sectional study. Place and Duration of Study: Department of Gastroenterology, Pak Emirates...

Full description

Bibliographic Details
Main Authors:	Anum Khan, Asif Farooq, Abdul Rehman Arshad, Farrukh Saeed
Format:	Article
Language:	English
Published:	Army Medical College Rawalpindi 2021-12-01
Series:	Pakistan Armed Forces Medical Journal
Subjects:	chronic hepatitis b medication non-adherence
Online Access:	https://www.pafmj.org/index.php/PAFMJ/article/view/2983/3733

Similar Items

Adherence and perceived barriers to oral antiviral therapy for chronic hepatitis B
by: Kerui Xu, et al.
Published: (2018-01-01)

Adherence to Nucleoside/Nucleotide Analogue Treatment in Patients with Chronic Hepatitis B
by: Emin Ediz Tütüncü, et al.
Published: (2017-12-01)

Dynamics of Hepatitis B Virus Pregenomic RNA in Chronic Hepatitis B Patients With Antiviral Therapy Over 9 Years
by: Jiali Pan, et al.
Published: (2022-04-01)

Adherence to Anti-Viral Treatment for Chronic Hepatitis B
by: Naim Abu-Freha, et al.
Published: (2020-06-01)

Low-level viremia and cirrhotic complications in patients with chronic hepatitis B according to adherence to entecavir
by: Seung Bum Lee, et al.
Published: (2020-07-01)

Case report: Unusual viral evolutions following antiviral therapies in a patient with concurrent hepatitis B virus and hepatitis C virus infection
by: Yi-Tse Su, et al.
Published: (2023-02-01)

Poor adherence is a contributor to viral breakthrough in patients with chronic hepatitis B
by: Wang L, et al.
Published: (2018-11-01)

Multifaceted Interaction Between Hepatitis B Virus Infection and Lipid Metabolism in Hepatocytes: A Potential Target of Antiviral Therapy for Chronic Hepatitis B
by: Jiaxuan Zhang, et al.
Published: (2021-03-01)

Molecular detection of hepatitis B virus genotype E with immune escape mutations in chronic hepatitis B patients on long-term antiviral therapy in Jos, Nigeria
by: Joseph Anejo-Okopi, et al.
Published: (2022-10-01)

Treatment Adherence to Nucleos(t)ide Analogs in Chinese Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma: A Single-Center Cross-Sectional Study
by: Li Y, et al.
Published: (2021-08-01)

Factors Associated with Hepatitis B Medication Adherence and Persistence among Underserved Chinese and Vietnamese Americans
by: Aisha Bhimla, et al.
Published: (2022-02-01)

The efficacy of antiviral treatment in chronic hepatitis B patients with hepatic steatosis
by: Danqing Hu, et al.
Published: (2024-04-01)

Occult Hepatitis B Virus Infection
by: Aslı Gamze ŞENER
Published: (2006-09-01)

Hepatitis B Virus-Associated Hepatocellular Carcinoma
by: Giacomo Emanuele Maria Rizzo, et al.
Published: (2022-05-01)

Prophylactic Antiviral Treatment in Immunosuppressed Chronic Hepatitis B Patients
by: Eileen L. Yoon
Published: (2019-11-01)

Evaluation of Response to Interferon Therapy in Chronic Hepatitis B and Chronic Hepatitis C Patients
by: Hakan LEBLEBİCİOĞLU, et al.
Published: (2001-09-01)

Adherence to the three-component Hepatitis B virus vaccination protocol among healthcare workers in hepatitis B virus endemic settings in Ghana
by: Senoo-Dogbey Vivian Efua, et al.
Published: (2024-01-01)

Factors and virological significance of hepatitis B virus pregenomic RNA status after 5 years of antiviral therapy
by: Jiali Pan, et al.
Published: (2021-04-01)

Antiviral Therapy of Chronic Hepatitis B Virus between Present and Future
by: Mariana Daniela Ignat, et al.
Published: (2024-04-01)

A study on outcome of hepatic fibrosis in chronic hepatitis B patients on anti-viral therapy
by: Avick Nag, et al.
Published: (2024-02-01)

Options for the management of antiviral resistance during hepatitis B therapy: reflections on battles over a decade
by: Hyung Joon Yim, et al.
Published: (2013-09-01)

Hepatitis B virus infection and vaccine-induced immunity in Madrid (Spain)
by: Ana María Pedraza-Flechas, et al.
Published: (2014-11-01)

Antiviral efficacy of entecavir for hepatitis B virus rtA181V/T mutants
by: Ping Li, et al.
Published: (2017-04-01)

The Effect of Antiviral Therapy with Tenofovir on Liver Fibrosis and Liver Function in Patients with Chronic Hepatitis B
by: Seyyed Saeed Sarkeshikian, et al.
Published: (2018-06-01)

The epidemiology of hepatitis B virus infection in Korea
by: Sun Young Yim, et al.
Published: (2019-09-01)

Hepatocellular Carcinoma in Hepatitis B Virus-Infected Patients and the Role of Hepatitis B Surface Antigen (HBsAg)
by: Satinder P. Kaur, et al.
Published: (2022-02-01)

Is it necessary to delay antiviral therapy for 3-6 months to anticipate HBeAg seroconversion in patients with HBeAg-positive chronic hepatitis B in endemic areas of HBV genotype C?
by: Byung-Cheol Song, et al.
Published: (2014-12-01)

The influence of hepatitis B virus on antiviral treatment with interferon and ribavirin in Asian patients with hepatitis C virus/hepatitis B virus coinfection: a meta-analysis
by: Liu Jun-Ying, et al.
Published: (2012-09-01)

Entecavir Treatment in Children and Adolescents with Chronic Hepatitis B Virus Infection
by: Kai-Chi Chang, et al.
Published: (2016-10-01)

The efficiency of antiviral therapy in patients with chronic hepatitis C infected with hepatitis C virus recombinants
by: N D Yushchuk, et al.
Published: (2016-06-01)

Activación linfocitaria en portadores del virus de la hepatitis B
by: Georgina Rousseau González, et al.
Published: (2000-03-01)

The Study of Clinical and Biochemical Parameters in Assessing the Response to the Antiviral Therapy in the Chronic Viral Hepatitis B
by: Alice Elena Ghenea, et al.
Published: (2021-07-01)

Predictive Factors for Sustained Remission after Discontinuation of Antiviral Therapy in Patients with HBeAg-positive Chronic Hepatitis B
by: Baek Gyu Jun, et al.
Published: (2016-01-01)

IMMUNOPATHOGENESIS OF OCCULT INFECTION CAUSED BY HEPATITIS B VIRUS
by: T. A Semenenko, et al.
Published: (2015-12-01)

Dynamic Characteristics of Serum Hepatitis B Surface Antigen in Chinese Chronic Hepatitis B Patients Receiving 7 Years of Entecavir Therapy
by: Xia-Xia Zhang, et al.
Published: (2016-01-01)

Hepatitis B Virus Inactive Carriers: Which Follow-up Strategy?
by: Maria João Magalhães, et al.
Published: (2015-03-01)

MOLECULAR BIOLOGY OF HEPATITIS B VIRUS AND IMMUNOPATHOGENESIS OF CHRONIC VIRAL HEPATITIS B
by: I. P. Balmasova, et al.
Published: (2016-04-01)

Impact of IL28B gene variants (rs12979860) in peg-IFN therapy against Chronic Hepatitis B Pakistani patients
by: Irfan Kalam, et al.
Published: (2018-11-01)

Current Condition of Chronic Hepatitis B Virus Infection in Cuban Adults
by: Castellanos Fernández Marlen Ivón, MD, PhD, MP, et al.
Published: (2017-01-01)

A Review of the Systemic Manifestations of Hepatitis B Virus Infection, Hepatitis D Virus, Hepatocellular Carcinoma, and Emerging Therapies
by: Katerina Roma, et al.
Published: (2024-01-01)